MAPT and Alzheimer disease: The intracellular deposition of the protein tau as amyloid fibrils characterizes a heterogeneous group of more than 20 neurodegenerative diseases, called tauopathies, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), among others1.